Zooomy, the fast‑rising veterinary‑developed joint‑care supplement for dogs and cats, is returning to PATS 2026 (Stand O2) for its second consecutive year – this time with even greater momentum, a significantly expanded customer base, and the launch of its pioneering mobility‑tracking web app.
Developed by veterinary surgeons Humphrey and Joanna Grimmett, Zooomy has rapidly become one of the UK’s most disruptive joint‑support brands. Zooomy is a ground‑breaking health supplement for dogs and cats which is designed to support their joint care using “long‑chain Hyaluronic Acid as the key ingredient. This scientifically validated formula has reshaped expectations of joint care for pets and established Zooomy as a credible alternative to glucosamine, chondroitin and short‑chain HA products.
A Year of Exceptional Growth
Zooomy’s second appearance at PATS comes on the back of extraordinary commercial performance:
- 698% year‑on‑year sales growth
- 1,100% increase in subscription revenue
- Over 9,000 customers across Shopify and Amazon
- 48.2% repeat purchase rate, with 31% returning for a third order
Zooomy has evolved from a newcomer to one of the fastest‑growing joint‑support products in the UK. Its second year at PATS marks a major milestone in its national expansion.
Introducing the Zooomy Mobility‑Tracking App
Zooomy’s presence at PATS 2026 will spotlight its new digital innovation: the Zooomy mobility‑tracking web app, designed to help owners monitor their dog’s joint health over time. The app strengthens Zooomy’s identity as a knowledge‑led mobility brand.
This digital tool offers retailers and professionals a new way to engage customers and reinforce long‑term mobility care.
Veterinary‑Led, Science‑Driven Joint Support
Zooomy’s long‑chain Hyaluronic Acid formula replenishes depleted HA levels in joint fluid—an issue that can reach up to 90% depletion in older, severely diseased joints. The mega‑chain HA is produced via microbial fermentation, ensuring purity, consistency and suitability for pets with allergies or sensitivities.
The liquid is odourless and tasteless making it ideal for fussy eaters and is administered by a syringe to the mouth which avoids the battle with pills, powders and chews.
Award‑Winning Brand Recognition
Zooomy’s second year at PATS follows a series of industry accolades:
- Finalist: Pet Industry Federation Awards 2025
- Finalist: Pet Product Marketing Retail Awards 2026
- Winner: Branding Award – Veterinary Marketing Association Awards 2026
The VMA win highlights Zooomy’s standout identity, scientific clarity and veterinary credibility.
Deepening Community Loyalty
Zooomy has cultivated strong loyalty among raw‑feeding communities, senior‑dog owners, physiotherapists, hydrotherapists and behaviourists. The brand’s affiliate programme gives professionals access to veterinary guidance, ensuring recommendations are based on welfare and science—not trends.
Zooomy’s vet team provides direct Q&A support, responding to every query and comment. As Humphrey says, “we are always on call to help.”
Sustainable, Responsible, Evidence‑Based
All Zooomy packaging is fully recyclable, including PET bottles, HDPE syringes and recyclable cardboard. Ethical sourcing and evidence‑based education remain central to the brand’s mission.
Zooomy at PATS 2026 – What Visitors Will See
At this year’s show, Zooomy will present:
- The Zooomy mobility‑tracking app
- Live veterinary‑led demonstrations of HA joint support
- Senior‑dog mobility guidance
- Trade and stockist partnership opportunities
- Affiliate programme information
- Exclusive PATS offers for retailers
Zooomy’s second year at PATS marks a new phase in its national growth—cementing its position as one of the UK’s most exciting, scientifically credible and fast‑advancing pet‑health brands.
Website: www.zooomy.com Facebook: facebook.com/zooomydog Instagram: instagram.com/zooomydog TikTok: tiktok.com/@zooomydog
